Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK2 | Q13002 | 2/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | CD81 | P60033 | 1/20 | 0.34 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | EP300 | Q09472 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17817 | 0.97 | — | — | |
| SCHEMBL5716965 | 0.97 | — | — | |
| SCHEMBL17819 | 0.97 | — | — | |
| Oxalic Acid SCHEMBL7522641 | 0.94 | GRIK2 (0.39) | GRIK2GRIK1PTGS1AKR1C3CD81 | |
| Water SCHEMBL11376129 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL534130 | 0.94 | — | — | |
| Bromide SCHEMBL9604104 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL7522649 | 0.94 | GRIK2 (0.39) | GRIK2GRIK1PTGS1AKR1C3CD81 | |
| Hydrochloric Acid SCHEMBL2564983 | 0.94 | — | — | |
| Bicarbonate SCHEMBL10996733 | 0.94 | GRIK2 (0.39) | GRIK2GRIK1PTGS1AKR1C3CD81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180346629-A1 | Biocompatible polymers and co-polymers, and uses thereof | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2018-12-06 | — | — | US | disclosed |
| EP-2292672-B1 | Biocompatible polymers and co-polymers comprising amino acids in the side chain | CIS PHARMA AG (CH) | 2018-05-09 | — | — | EP | disclosed |
| US-9839719-B2 | Biocompatible polymers and co-polymers, and uses thereof | CIS PHARMA AG (CH) | 2017-12-12 | — | — | US | disclosed |
| US-20170152335-A1 | Biocompatible polymers and co-polymers, and uses thereof | HITZ HANS (CH) | 2017-06-01 | — | — | US | disclosed |
| EP-1888660-B1 | BIOCOMPATIBLE POLYMERS AND CO-POLYMERS COMPRISING AMINO ACIDS IN THE SIDE CHAIN | CIS PHARMA AG (CH) | 2017-05-17 | — | — | EP | disclosed |
| EP-2523982-B1 | METHODS FOR THE PREPARATION OF BIOCOMPATIBLE POLYMERS, THE POLYMERS AND THEIR USES | CIS PHARMA AG (CH) | 2015-04-29 | — | — | EP | disclosed |
| US-8980957-B2 | Methods for the preparation of biocompatible polymers, the polymers and their uses | CIS PHARMA AG (CH) | 2015-03-17 | — | — | US | disclosed |
| US-20120329902-A1 | METHODS FOR THE PREPARATION OF BIOCOMPATIBLE POLYMERS, THE POLYMERS AND THEIR USES | SCHAEFER ROLF (CH) | 2012-12-27 | — | — | US | disclosed |
| EP-2523982-A1 | METHODS FOR THE PREPARATION OF BIOCOMPATIBLE POLYMERS, THE POLYMERS AND THEIR USES | Chemisches Institut Schaefer AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011085988-A1 | METHODS FOR THE PREPARATION OF BIOCOMPATIBLE POLYMERS, THE POLYMERS AND THEIR USES | CHEMISCHES INSTITUT SCHAEFER AG (CH) | 2011-07-21 | — | — | WO | disclosed |
| EP-2292672-A2 | Biocompatible polymers and co-polymers comprising amino acids in the side chain | Chemisches Institut Schaefer AG (CH) | 2011-03-09 | — | — | EP | disclosed |
| US-20090232871-A1 | Biocompatible polymers and co-polymers, and uses thereof | HITZ HANS | 2009-09-17 | — | — | US | disclosed |
| EP-1888660-A2 | BIOCOMPATIBLE POLYMERS AND CO-POLYMERS COMPRISING AMINO ACIDS IN THE SIDE CHAIN | Chemisches Institut Schaefer AG (CH) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006126095-A2 | BIOCOMPATIBLE POLYMERS AND CO-POLYMERS COMPRISING AMINO ACIDS IN THE SIDE CHAIN | CHEMISCHES INSTITUT SCHAEFER AG (CH) | 2006-11-30 | — | — | WO | disclosed |
| US-4323467-A | POLYOXYALKYLENE ETHYLENEDIAMINE NONIONIC SURFACTANT | SYNTEX (U.S.A.) INC. (US) | 1982-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090232871-A1 | Biocompatible polymers and co-polymers, and uses thereof | PPIH, ARG1, P4HA1 | GRIK2 2002/4885GRIK1 2806/4885PTGS1 136/4885 |
| US-20170152335-A1 | Biocompatible polymers and co-polymers, and uses thereof | ARG1, CRYAA, COL1A1 | GRIK2 2589/4885GRIK1 2024/4885PTGS1 485/4885 |
| US-20180346629-A1 | Biocompatible polymers and co-polymers, and uses thereof | ARG1, CRYAA, COL1A1 | GRIK2 2589/4885GRIK1 2024/4885PTGS1 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.